Join us for an insightful panel discussion on "Lung in Diabetes," where leading experts will delve into the complex relationship between lung health and diabetes management. Our distinguished speakers will share their knowledge on respiratory complications associated with diabetes, including asthma and COPD, and discuss the impact of glycemic control on lung function. The session will also cover risk assessment strategies, preventive measures, and the latest treatment options available for patients. This is an invaluable opportunity for healthcare professionals to enhance their understanding of how to optimize lung health in individuals with diabetes and stay informed on current best practices. Don't miss this chance to engage with experts and deepen your clinical expertise!

Panel Discussion on Diabetes Lung

Continuous glucose monitors (CGM) continuously monitor the glucose (sugar) in your blood via an external device attached to your body and provides real-time data. They've grown in popularity and accuracy over the years, and with that has come a new technique to regulate your blood glucose. "The Time In Range" approach uses your CGM data to determine how long your blood glucose has been in target range and how many times you've been high (hyperglycemia) or low (hypoglycemia). In this session, you'll gain valuable insights into how CGM technology is revolutionizing glycemic control, enabling personalized treatment strategies, and improving patient outcomes. Don't miss this opportunity to grasp the essentials of Time in Range and its potential impact on enhancing diabetes management.

Time in range, CGM

RCP Diabetology Day-5

CEO & Chief Endocrinologist, Chellaram Diabetes Institute, Pune

Persistent hypertension despite treatment can often point towards underlying aldosterone-mediated mechanisms. This expert-led session will explore the role of aldosterone in difficult-to-control hypertension, approaches to identifying patients with aldosterone-driven disease, and evolving strategies for targeted management. The discussion will also examine the emerging role of Aldosterone Synthase Inhibitors (ASI) and their potential to address unmet needs in patients with persistently uncontrolled blood pressure. Featuring insights from Dr. Vijay Kher, Prof. Dr. David Wheeler, and Dr. A G Unnikrishnan, the session will focus on practical perspectives and the evolving evidence shaping the future of hypertension management.

Dr. AG Unnikrishnan

5

913

36.2k

4.7

Upcoming Sessions

Sessions Taken

153

0

153

4.7

753

4.7

0

0